Treatment for Vulvovaginal Mycotic Infections: FarmaImpresa Group certifies a new Medical Device in Macedonia
We have completed the registration with the competent authorities in Macedonia for a Class I medical device, designed for the treatment of vulvovaginal mycotic infections.
The medical device is formulated as a vaginal suppository based on hyaluronic acid, boric acid, and lactic acid selected for their beneficial properties in combating vaginal inflammations and infections. The product is specifically indicated for inflammatory and infectious conditions, offering an effective solution for the prevention and treatment of vaginal dryness.
Due to its composition, the medical device has proven effective in cases of vaginal irritation, including vaginitis and bacterial vaginosis, providing immediate relief from symptoms such as burning and itching.
The hyaluronic acid present in the formulation acts as a natural moisturizer, helping to maintain a balanced and healthy vaginal environment. Boric acid, known for its antifungal properties, proves particularly useful in combating mycotic infections, while lactic acid helps maintain the vaginal pH balance.
Thanks to this combination of ingredients, the medical device represents a comprehensive solution for various issues related to vaginal health.
The registration with Macedonian authorities underscores our company’s commitment to providing quality products, subjected to rigorous controls and approved by competent institutions.
Continue to follow us to stay updated on our upcoming certifications worldwide.
